Not applicableStudy completedNCT00257647What this trial is testingUse of SV40 Vectors to Treat Chronic Myeloid Leukemia (CML)Who this might be right forChronic Myeloid Leukemia Hadassah Medical Organization 25
Large-scale testing (Phase 3)UnknownNCT01400074What this trial is testingEfficacy of Nilotinib Versus Imatinib in Ph+ CML in Early CP Who Have a Suboptimal Molecular Response to ImatinibWho this might be right forChronic Myeloid Leukemia Seoul St. Mary's Hospital 100
Testing effectiveness (Phase 2)Study completedNCT00334074What this trial is testingClofarabine and Ara-C for the Treatment of Relapsed AML and Untreated MDSWho this might be right forAcute Myelogenous LeukemiaMyelodysplastic SyndromesChronic Myelogenous Leukemia Baylor Research Institute 30
Early research (Phase 1)Study completedNCT00301938What this trial is testing7-Hydroxystaurosporine and Perifosine in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia or High Risk Myelodysplastic SyndromesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)+23 more National Cancer Institute (NCI) 30
Early research (Phase 1)WithdrawnNCT04464889What this trial is testingHA-1H TCR T Cell for Relapsed/Persistent Hematologic Malignancies After Allogeneic Stem Cell TransplantationWho this might be right forAcute Myeloid LeukemiaAcute Lymphoid LeukemiaMyelodysplastic Syndromes+5 more Medigene AG
Testing effectiveness (Phase 2)Ended earlyNCT02543749What this trial is testingDC Vaccination in CMLWho this might be right forMyeloid Leukemia, Chronic Charite University, Berlin, Germany 1
Testing effectiveness (Phase 2)Study completedNCT00267085What this trial is testingSynthetic Vaccine in Patients With Chronic Myeloid Leukemia and Minimal Residual DiseaseWho this might be right forChronic Myeloid LeukemiaMinimal Residual Disease M.D. Anderson Cancer Center 11
Early research (Phase 1)Study completedNCT00420043What this trial is testingEffect of Food on Bioavailability of Modified Release Formulations of ImatinibWho this might be right forHealthy Novartis 32
Large-scale testing (Phase 3)Temporarily pausedNCT01755325What this trial is testingPhase III Study of Compound Formula Realgar-Indigo Naturalis Plus Imatinib Versus Placebo Plus Imatinib in Adult CML-CP Patients With Ph+Who this might be right forChronic Myelogenous Leukemia Junmin Li 680
Early research (Phase 1)Ended earlyNCT01751425What this trial is testingRuxolitinib in Treating Participants With Chronic Myeloid Leukemia With Minimal Residual Disease While on Therapy With Tyrosine Kinase InhibitorsWho this might be right forChronic Myelogenous Leukemia, BCR-ABL1 PositiveChronic Myelogenous Leukemia, BCR-ABL1 Positive in RemissionMinimal Residual Disease+1 more M.D. Anderson Cancer Center 8
Testing effectiveness (Phase 2)Study completedNCT01207440What this trial is testingPonatinib for Chronic Myeloid Leukemia (CML) Evaluation and Ph+ Acute Lymphoblastic Leukemia (ALL)Who this might be right forChronic Myeloid LeukemiaPh+ Acute Lymphoblastic Leukemia Ariad Pharmaceuticals 449
Large-scale testing (Phase 3)Active Not RecruitingNCT05456191What this trial is testingInvestigate Tolerability and Efficacy of Asciminib (Oral) Versus Nilotinib (Oral) in Adult Participants (≥18 Years of Age) With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP)Who this might be right forPhiladelphia Chromosome-Positive Chronic Myeloid Leukemia Novartis Pharmaceuticals 568
Testing effectiveness (Phase 2)Ended earlyNCT00644878What this trial is testingStudy of Molecular Response in Adult Patients on Nilotinib With Philadelphia Chromosome Positive Chronic Myelogenous Leukemia (Ph+ CML) in Chronic Phase and a Suboptimal Molecular Response to ImatinibWho this might be right forChronic Myelogenous Leukemia - Chronic Phase Novartis Pharmaceuticals 18
Early research (Phase 1)Ended earlyNCT02841540What this trial is testingH3B-8800 (RVT-2001) in Participants With Lower Risk Myelodysplastic SyndromesWho this might be right forLeukemia, Myeloid, AcuteMyelodysplastic SyndromesLeukemia, Myelomonocytic, Chronic Hemavant Sciences GmbH 127
Early research (Phase 1)Study completedNCT00027144What this trial is testingStudy Using Vaccination With Heat Shock Protein 70 (HSP70) for the Treatment of CML in Chronic PhaseWho this might be right forLeukemia,Myeloid, ChronicLeukemia,Myeloid,Philadelphia-Positive University of Connecticut 10
Testing effectiveness (Phase 2)Ended earlyNCT00415909What this trial is testingTALL-104 and Gleevec in Chronic Myelogenous Leukemia PatientsWho this might be right forChronic Myelogenous Leukemia M.D. Anderson Cancer Center 3
Testing effectiveness (Phase 2)Study completedNCT00375219What this trial is testingHomoharringtonine (Omacetaxine Mepesuccinate) in Treating Patients With Chronic Myeloid Leukemia (CML) With the T315I BCR-ABL Gene MutationWho this might be right forChronic Myeloid Leukemia Teva Branded Pharmaceutical Products R&D, Inc. 103
Testing effectiveness (Phase 2)Study completedNCT01804985What this trial is testingDe- Escalation and Stopping Treatment of Imatinib, Nilotinib or sprYcel in Chronic Myeloid LeukaemiaWho this might be right forChronic Myeloid Leukaemia University of Liverpool 174
Early research (Phase 1)Study completedNCT00002750What this trial is testingMelphalan in Patients With Neoplastic MeningitisWho this might be right forBrain and Central Nervous System TumorsExtragonadal Germ Cell TumorLeukemia+2 more Duke University 6
Testing effectiveness (Phase 2)Study completedNCT00171249What this trial is testingAn Extension Study to Determine the Safety and Anti-Leukemic Effects of Imatinib Mesylate in Adult Participants With Ph+ LeukemiaWho this might be right forPhiladelphia Positive Chronic Myeloid LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia Novartis Pharmaceuticals 293